Go to main navigation Navigation menu Skip navigation Home page Search

SSE Alumni Webinar: Life Science after the pandemic

Join us for this unique Q&A with Pfizer Medical Director Christoph Varenhorst, exclusively available for SSE Alumni.

COVID-19 has radically changed research and the pharmaceutical industry in many ways. In a short amount of time, paradigm-shifting mRNA vaccines went from pipe dream to mainstream.

What type of leadership is necessary when everything is in flux? What did Pfizer's leadership learn from the pandemic? Join us to listen to Pfizer’s Medical Director Christoph Varenhorst who will discuss these questions in this exclusive lunch session arranged by the SSE Alumni Office and the SSE Alumni Network for Health and Life Sciences. 

Please note that this is a closed event for a maximum of 30 guests, with no recordings allowed. 


(Photo: Kate Gabor)

Christoph Varenhorst

MD, PhD, Associate Professor. Christoph is the country Medical Director and leading all in-country medical functions at Pfizer Sweden and is part of the country leadership team. He has previously worked as a senior consultant in interventional cardiology at Uppsala University Hospital and a senior faculty member at Uppsala Clinical Research Center.



Jonathan Ilicki

MD, MSc. Jonathan is Head of Medical Innovation at Platform24, where he leads the development of new health tech ventures. He has previously worked as a physician within emergency medicine, a startup founder and a management consultant.


This website uses cookies. By using this website you are agreeing to our use of cookies and to the terms and conditions listed in our data protection policy. Read more